The first developed technology platform with various application scenarios, including infectious disease, fertility, DOA, etc.
50+ kinds of reagents and five high-performance devices, focusing on detecting cardiovascular disease, inflammation, kidney injury, sex hormones, thyroid function, diabetes, tumor, and others.
Wondfo optical blood coagulation analyzer is the first one in the world that can test PT, APTT, TT, FIB, and ACT simultaneously.
Our Blood Gas Analyzer BGA-102 can produce the result in 30s. Its advantages of portability, easy operation, durability, and high performance make it ideal for clinics, laboratories, and hospitals.
Wondfo Dry Chemistry Analyzer can test 16 items and provide the result within 2 minutes, ideal for the detection of cardiac markers, kidney function, liver function, pancreatitis, etc.
Ready-to-use lyophilized RT-PCR Reagent;
Gold Standard for COVID-19 Diagnosis
Wondfo Respiratory Syncytial Virus Antigen Test is an immunochromatographic assay for rapid, qualitative detection of Respiratory Syncytial Virus (RSV) antigen extracted from the nasopharyngeal swab or oropharyngeal swab specimen. The test is to be used as an aid in the diagnosis of RSV infection disease, which is caused by RSV antigen.
Wondfo Flu A&B/2019-nCoV/RSV/ADV/MP Antigen Combo Test is a qualitative screening in vitro diagnostic test designed for use by healthcare professionals. It detects six respiratory pathogen antigens: Influenza A, Influenza B, 2019 Novel Coronavirus (2019-nCoV), Respiratory Syncytial Virus (RSV), Adenovirus (ADV), and Mycoplasma Pneumoniae (MP) in human nasopharyngeal and oropharyngeal swab specimens. This user-friendly test requires no additional equipment, delivers results in 15 minutes, and is suitable for various healthcare settings. It serves as an efficient screening method, particularly valuable during flu seasons and epidemics, to aid in swift identification and potential isolation of infectious cases.